Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W5YY
|
|||
Former ID |
DNCL002177
|
|||
Drug Name |
PM-060184
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
Company |
PharmaMar
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C31H45N3O7
|
|||
Canonical SMILES |
CC=CCC(CC=CNC(=O)C(C(C)(C)C)NC(=O)C=CC=CC(=CC(C)C1CC=C(C(=O)O1)OC)C)OC(=O)N
|
|||
InChI |
1S/C31H45N3O7/c1-8-9-14-23(40-30(32)38)15-12-19-33-28(36)27(31(4,5)6)34-26(35)16-11-10-13-21(2)20-22(3)24-17-18-25(39-7)29(37)41-24/h8-13,16,18-20,22-24,27H,14-15,17H2,1-7H3,(H2,32,38)(H,33,36)(H,34,35)/b9-8-,13-10-,16-11-,19-12-,21-20+/t22-,23-,24-,27+/m0/s1
|
|||
InChIKey |
IEKGSKLKBICCHQ-BDOJOPHNSA-N
|
|||
CAS Number |
CAS 960210-99-5
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01299636) Study of PM060184 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.